Synthetic recombinant vaccine induces anti-influenza long-term immunity and cross-strain protection.
Arnon
R
R
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Levi
R
R
D000818:Animals; D003429:Cross Reactions; D006801:Humans; D007111:Immunity, Cellular; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D051379:Mice; D008807:Mice, Inbred BALB C; D011994:Recombinant Proteins; D013045:Species Specificity; D014614:Vaccines, Synthetic
D007252:Influenza Vaccines; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic